Xspray-logo-white
  • Home
  • About us
    • Business model
    • Our history – a timeline
    • Board of Directors & Board committees
    • Management
  • Technology
  • Pipeline
  • Media
  • Contact
  • Investors
  • en en
    • sv sv
  • Investors
    • Share information
      • Ownership structure
    • Financial calendar
    • Financial reports
      • ESEF report
    • Prospectus
    • Press releases
    • Corporate governance
      • Corporate Structure
      • General meetings
      • Corporate Governance Reports
      • Nomination committee
      • Board of Directors & Board committees
      • Management
      • Accounting principles
      • Internal control & Risk management
      • Auditor
      • Articles of association
      • Remuneration

Press releases

All press releases Regulatory

Regulatory press release 2019-06-27

Successful production start for HyNap-Dasa in Xspray’s unique full-scale production line

Regulatory press release 2019-06-11

Xspray granted additional product patents in the United States for HyNap-Sora and HyNap-Nilo

Regulatory press release 2019-02-18

Xspray Pharma announces positive clinical data for the drug candidate HyNap-Sora

Regulatory press release 2018-12-06

Xspray Pharma has carried out a directed share issue raising gross proceeds of approximately SEK 92 million

Regulatory press release 2018-12-06

Xspray Pharma contemplates a directed share issue to continue development of its product portfolio

Regulatory press release 2018-12-04

Additional product patent in the United States for HyNap-Dasa

Regulatory press release 2018-10-25

Xspray Pharma prepares for listing on main list

Regulatory press release 2018-10-25

Notice of extraordinary general meeting in Xspray Pharma AB (publ)

Regulatory press release 2018-10-10

Xspray Pharma’s HyNap-Dasa Shows Formal Bioequivalence

Regulatory press release 2018-09-24

Ribbskottet AB increases its stake in Xspray Pharma

Show more

IR contact

Jacob Nyberg, IRO

+46 (0)70 767 08 83

info@xspray.com

Subscribe

  • This field is for validation purposes and should be left unchanged.
  • Submit to our press releases and get an email every time we publish a press release or report on our website.
  • When clicked on Send I agree that my personal information will be saved. Read more
Xspray-logo-white

Xspray Pharma AB Scheeles väg 2 171 65 Solna

+46 (0)8 730 37 00 info@xspraypharma.com